Effective treatment of different H1-antihistaminerefractory chronic urticaria phenotypes with omalizumab
(Turk Arch Pediatr 2018; 53: 250-254) DOI: 10.5152/TurkPediatriArs.2016.4042
(Turk Arch Pediatr 2018; 53: 250-254) DOI: 10.5152/TurkPediatriArs.2016.4042
Öner Özdemir, Hayrunnisa Bekis , Bahri Elmas
(Turk Arch Pediatr 2017; 52: 105-107) DOI: 10.5152/TurkPediatriArs.2017.2262